Medtech Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

From Military To Medicine, Owlstone Medical Targets Lung Cancer With Its Breath Analysis Tech

Executive Summary

Owlstone Medical is on a mission to “save 100,000 lives and £1.5bn in health-care costs by 2020” by applying a gas sensor technology, originally developed for military defense purposes, for early stage detection of lung cancer.


Related Content

Can New Wave Of Tests Finally Nail Early Diagnosis Of Lung Cancer?